跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,241 条关于
“BCR::ABL”
全部
9,241
临床试验
6,891
药物
1,021
机构
325
资讯
1,004
9个月前
Terns Pharmaceuticals Closes $747.5 Million Public Offering to Advance BCR-ABL Inhibitor TERN-701
6个月前
Digital PCR Outperforms Standard RT-qPCR in Detecting Residual BCR::ABL1 in CML Patients, Enabling Better TKI Discontinuation Decisions
去年
Terns Pharma's TERN-701 Shows Promise in Phase I CML Trial
去年
Enliven Therapeutics' ELVN-001 Shows Promising Phase 1 Data in Chronic Myeloid Leukemia
去年
Olverembatinib's New Indication for CML-CP Included in China's NRDL
去年
FDA Approves Scemblix (asciminib) for First-Line Treatment of Chronic Myelogenous Leukemia
去年
Novartis Receives CDSCO Approval for Phase IIIb Trial of Asciminib in Chronic Myeloid Leukemia
去年
FDA Grants Breakthrough Therapy Designation to Olverembatinib for Ph+ Leukemia Treatment
3年前
Asciminib Demonstrates Durable Efficacy and Safety in Heavily Pretreated CML-CP Patients
5个月前
Flumatinib Therapeutic Drug Monitoring Reveals Key Exposure Thresholds for Molecular Response in Chinese CML-CP Patients
第 1 页,共 101 页
上一页
下一页